AccuDial

AccuDial Pharmaceutical, Inc. consists of two business units, namely AccuDial® Pharmaceutical and Spinformation®. AccuDial® Pharma offers a variety of over-the-counter (OTC) and nutraceutical products for children and adults in both liquid and pill forms. The global total addressable market for AccuDial® pharmaceutical business unit is approximately $3 billion. The company leverages our patented Spinformation® label technology to differentiate AccuDial® products from domestic and store brand manufacturers in China.